Between a Rock and a Hard Place: How to Use Antithrombotics in Patients Undergoing Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) has become the preferred method for management of severe aortic stenosis in patients who are at high and intermediate surgical risk, and has recently gained approval from the Food and Drug Administration in the US for use in patients at low risk for surg...
Saved in:
| Main Authors: | Kelsey Grossman, Mathew R Williams, Homam Ibrahim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2020-02-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articles/Antithrombotics-Transcatheter-Aortic-Valve-Replacement |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimal antithrombotic therapy after transcatheter aortic valve replacement: a comprehensive review
by: Nguyen Van Thai Thanh, et al.
Published: (2025-03-01) -
Antithrombotic strategies after transcatheter aortic valve replacement a network meta-analysis
by: Mengxiao Shi, et al.
Published: (2025-05-01) -
Stroke in Patients Undergoing Transcatheter Aortic Valve Replacement: Embracing the Unpredictable
by: Ahmed Elkaryoni, et al.
Published: (2024-09-01) -
Redo-Transcatheter Aortic Valve Replacement: Strategies When the First Transcatheter Aortic Valve Replacement Fails
by: Nils Perrin, et al.
Published: (2022-03-01) -
Periprocedural care for frail older patients with aortic stenosis undergoing transcatheter aortic valve replacement
by: Joshua Eng, et al.
Published: (2025-06-01)